ARTICLE | Company News
Sangamo, Bristol-Myers deal
April 10, 2000 7:00 AM UTC
Sangamo will provide BMY its Universal GeneTools, which use engineered zinc finger DNA recognition proteins to regulate gene expression, for use in BMY's internal research and validation programs. ...